- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASRS 2022 to Highlight Novel Therapies and Trends in Care for Retina Specialists
The American Society of Retina Specialists (ASRS) will hold its 40th Annual Scientific Meeting in New York, New York, July 13-16, 2022.
Among the sessions on novel therapies in retinal care, the latest technologies in ophthalmology, and instructional courses, the results of the Preferences and Trends (PAT) Survey and Global Trends Survey will be presented at this year’s annual meeting of the American Society of Retina Specialists (ASRS).
The 40th Annual Scientific Meeting of ASRS will be held July 13-16, 2022, in New York, New York, and virtually. Each day of the meeting will feature the latest in wet and dry age-related macular degeneration, surgery, and diabetic retinopathy.
Among the clinical presentations are results on dosing strategies with anti–vascular endothelial growth factor and the efficacy of suprachoroidal triamcinolone acetonide injectable suspension to treat macular edema.
There are also 5 late-breaking presentations:
- Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
- Phase IIIb TALON Study of Brolucizumab Versus Aflibercept in a Matched Treat-and-Extend Regimen to Treat Neovascular AMD: 32-week Primary Outcomes
- 12-Month Results of EYP-1901 Vorolanib in a Bioerodible Durasert Insert for nAMD: The DAVIO Trial
- Benefits and Value of Treatment for Diabetic Macular Edema
- Phentolamine Ophthalmic Solution Rapidly Reverses Pharmacologically Induced Mydriasis in Two Pivotal Phase 3 MIRA Trials
In addition to clinical presentations, there will be a panel discussion on transformative technology and multiple presentations during a technology symposium section. The technology presentations include one on smartphone-based home vision monitoring, which is the Fellows Forum Award Winner.
On Friday, ASRS will present 9 awards, including the 2022 Founders Award, the ASRS Presidents’ Retina Young Investigators Award, and the Retina Hall of Fame Award.
Finally, the ASRS annual meeting will include the latest results of the annual PAT Survey and the Global Trends survey. These surveys review technologies being used, therapies being prescribed, what influences decisions for treatment, and more. Respondents are both based in the United States and internationally.
The ASRS meeting will close on Saturday, July 16, with poster and film awards.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
